Health and Fitness Health and Fitness
Thu, June 16, 2011
[ 09:24 AM ] - Market Wire
St. Jude Medical's AGA Medical Subsidiary Files Patent Infringement Lawsuits Against Occlutech
[ 09:15 AM ] - Market Wire
Phase I/II Data Evaluating Clinical Benefit of RE .. tandard R-CHOP Chemotherapy for Patients with Unt
[ 09:01 AM ] - Market Wire
POZEN Announces Election of Dr. Martin Nicklasson to the Board of Directors
[ 08:47 AM ] - Market Wire
Phase II Study Evaluates Clinical Benefit of Comb .. ab to Enhance Anti-Cancer Activity in Mantle Cell
[ 06:00 AM ] - Market Wire
Teleflex Completes Refinancing of Debt Capital St .. rmation to Pure-Play Medical Technology Company w
[ 05:52 AM ] - Market Wire
Seattle Genetics Announces FDA Advisory Committee .. n for the Treatment of Relapsed or Refractory Hod
[ 05:30 AM ] - Market Wire
Catasys Launches Its Integrated Substance Dependence Program in Kansas
[ 05:30 AM ] - Market Wire
Robert S. Vaters Named President and Chief Executive Officer
[ 05:00 AM ] - Market Wire
International Stem Cell Corporation (ISCO) Announ .. President and CEO of ZO SKIN HEALTH, the Luxury B
[ 04:35 AM ] - Market Wire
ARIAD Announces Broader Profile of Its Investigat .. date, AP26113, Showing Dual Inhibition of ALK and
[ 04:00 AM ] - Market Wire
Cubist Announces Positive Results from Two Phase 2 Trials, CXA-201 and CDAD Program
[ 04:00 AM ] - Market Wire
NanoViricides Announces That Its CEO Will Present .. ompany at an Investor Meeting June 16th in Denver
[ 04:00 AM ] - Market Wire
Arrowhead Research President & CEO Christopher An .. Featured in The Wall Street Transcript Interview
[ 03:05 AM ] - Market Wire
ZIOPHARM Oncology to Host Analyst & Institutional Investor Meeting on June 23, 2011
[ 01:00 AM ] - Market Wire
Santarus to Present at the Wells Fargo Securities 2011 Healthcare Conference
[ 12:20 AM ] - Market Wire
Dendreon Announces Webcast Presentation at NASDAQ OMX 26th Investor Program
[ 12:20 AM ] - Market Wire
ShangPharma Corporation Named a Top Ten Chinese Outsourcing Enterprise
Wed, June 15, 2011
[ 11:30 PM ] - Market Wire
COMPLETE Registry Provides First Glance into Trea .. erns for Patients with Peripheral T-Cell Lymphoma
[ 03:57 PM ] - Market Wire
Five Star Quality Care, Inc. Prices Offering of 10,000,000 Common Shares
[ 03:40 PM ] - Market Wire
TPI Signs Macrolide API International Sales and Marketing Agreement
[ 03:40 PM ] - Market Wire
MedCath Corporation Adopts Section 382 Rights Plan
[ 03:15 PM ] - Market Wire
Covidien kndigt Vernderungen im Unternehmen an
[ 03:14 PM ] - Market Wire
Covidien annonce des changements organisationnels
[ 03:13 PM ] - Market Wire
Covidien kondigt organisatorische veranderingen aan
[ 01:33 PM ] - Market Wire
Nipro Diagnostics and NeuroMetrix Announce Diabet .. ollaboration for the Retail Medical Clinic Market
[ 12:26 PM ] - Market Wire
SurModics Comments on Johnson & Johnson Announcement
[ 09:51 AM ] - Market Wire
Covidien anuncia cambios organizativos
[ 09:50 AM ] - Market Wire
Covidien anuncia mudanas organizacionais
[ 09:08 AM ] - Market Wire
Covidien annuncia cambiamenti nell'organizzazione dell'azienda
[ 07:00 AM ] - Market Wire
Alexion to Present at the Wells Fargo Securities Healthcare Conference

Alexion to Present at the Wells Fargo Securities Healthcare Conference


Published on 2011-06-15 08:15:31 - Market Wire
  Print publication without navigation


CHESHIRE, Conn.--([ BUSINESS WIRE ])--Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) today announced that Vikas Sinha, Chief Financial Officer of Alexion Pharmaceuticals, will present at the Wells Fargo Securities Healthcare Conference in Boston at 3:30 p.m., Eastern on Wednesday, June 22, 2011.

An audio webcast of Mr. Sinhaa™s remarks will be available live. You can access the webcast at: [ www.alexionpharma.com ]. An archived version of the remarks will also be available through the Companya™s web site for a limited time following the conference.

[ALXN-G]

Contributing Sources